Primary sclerosing cholangitis

Primary Sclerosing Cholangitis

BMO maintains Outperform rating for Cenovus Energy stock

Investing.com has reported that BMO is maintaining an Outperform rating for Cenovus Energy stock. This news comes amidst positive data from Pliant on bexotegrast in a liver disease trial. As developments in the medical and energy sectors continue to unfold, it is crucial for investors to stay informed on the latest updates.

Pliant reports positive data on bexotegrast in liver disease trial

Pliant's announcement of positive data on bexotegrast in a liver disease trial is a significant milestone in the field of medicine. This promising news underscores the importance of ongoing research and development efforts in finding effective treatments for various health conditions. As more data becomes available, it will be interesting to see how this breakthrough may impact the future of liver disease treatment.